The global electrophoresis market is projected to reach USD 2.80 billion by 2022 from USD 2.15 billion in 2017, at a CAGR of 5.4%. Factors such as rising prevalence of infectious diseases, growing incidence of cancer and genetic disorders, increased private and public investments as well as government funds and grants for specific disease-targeted genomic research, and increasing collaborative research projects between industry and academia are the key drivers of this market during the forecast period. Moreover, untapped emerging markets, increasing demand for personalized medicine, and shift from plant-derived to genome-based drug discovery are expected to offer potential growth opportunities to market players during the forecast period.
In this report, the market is segmented on the basis of product, application, end user, and region. On the basis of product, the global electrophoresis market is segmented into electrophoresis reagents, electrophoresis systems, gel documentation systems, and software. The gel documentation systems segment is expected to grow at the highest CAGR during the forecast period. Companies are also focusing on the approval and launch of gel documentation systems owing to substantial growth in the clinical research and drug industry.
Download PDF Brochure : http://www.marketsandmarkets.com/pdfdownload.asp?id=434
Based on application, the market is segmented into research, diagnostics, and quality control & process validation. The diagnostic applications segment is expected to grow at the highest CAGR during the forecast period. The high growth of this segment is driven by the growing use of electrophoresis in various preclinical and clinical diagnosis procedures. Furthermore, technological advancements such as the emergence of microchip capillary electrophoresis (CE) and its greater utilization in the diagnosis of many chronic and life-threatening diseases are also expected to contribute to the growth of this market.
Geographically, the electrophoresis market in the Asia-Pacific (APAC) region is expected to register the highest CAGR during the forecast period. This region is expected to grow at the highest pace during the forecast period, primarily due to the growing proteomics and genomics research & increasing research funding, rising adoption of advanced electrophoresis techniques, increasing investments by pharmaceutical and biotechnology companies, and growing research collaborations and funding.
The increasing integration of microfluidic/lab-on-chip technologies in capillary electrophoresis has helped overcome the limitations of SDS-PAGE and other separation techniques. Furthermore, the transition from manual electrophoresis systems to the automated electrophoresis systems has shown remarkable progress of electrophoresis instrumentation & techniques in recent years. However, the growing need to automate biomolecular analysis and ensure higher reproducibility, increased sensitivity, lower sample consumption, and faster analysis through electrophoresis techniques has led to the adoption of automated systems for genomics and proteomics.